Esperion files new drug submissions in Canada for Nexletol and Nexlizet as a treatment for reducing bad cholesterol and ...
The body needs some cholesterol to maintain good health. But for those who need to reduce the risk of a heart attack or stroke, statin drugs lower ... analysis in the New England Journal of ...
Esperion (ESPR) has filed New Drug Submissions to Health Canada for NEXLETOL and NEXLIZET, once-daily, accessible, oral non-statin medications ...
A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as ...
Esperion shares were up 13% to $3.16 after the company said it has filed New Drug Submissions to Health Canada for Nexletol and Nexlizet, non-statin medications that reduce low-density lipoprotein ...
A new study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as the ...
a class of drug that effectively reduces cholesterol. Guidelines for doctors do not recommend prescribing statins to diabetic patients unless they have high cholesterol levels. But the new ...
A UCLA study has outlined a new framework that researchers say would improve the predictive power of genetics to determine ...
has submitted New Drug Submissions to Health Canada for two cholesterol-lowering medications, NEXLETOL and NEXLIZET, the company announced today. These oral, non-statin drugs are designed to ...
ANN ARBOR, Mich. - Esperion (NASDAQ: NASDAQ:ESPR), which has seen remarkable revenue growth of 187% over the last twelve months, has submitted New Drug Submissions to Health Canada for two cholesterol ...
A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how ...
11, 2024 — Higher levels of HDL-C -- known as the 'good cholesterol' -- have ... risk for cardiovascular disease, a new ... Common Hair Loss and Prostate Drug May Also Cut Heart Disease Risk ...